Ruti Aga: Six-Year Ban Over a Forged Prescription — the Story Is Paper, Not Steroids

Three verification failures, all on one prescription. The clinic that issued it did not exist. The person who signed it was not a registered physician — she was a family member. And when asked where the form came from, the answer was "an old prescription pad from a former workplace" — a workplace that promptly disowned the claim.

This case is not about the marathon. It is about the paper.

I have a habit. After the 2026 Delhi Commonwealth Games I kept a sheet in a drawer — Krishna Poonia's 63.69m, and the women's 4x400 relay two nights later. Seven nights in that stadium taught me the difference between noise and a heartbeat. In the summer of 2026, when bans were confirmed for six women athletes, several of them from that same relay squad, I struck the word "golden" from my vocabulary. Since then every celebration carries an asterisk clause: what the supplement protocol was, who was tested and who was not, whether an appeal is pending.

Ruti Aga's case is that asterisk, defined.

A 32-year-old Ethiopian marathoner. Winner of the 2026 Tokyo Marathon. Three second-place finishes at World Marathon Majors. A 2:18-to-2:20 class athlete — the kind who does not automatically make an Ethiopian team, but would be the No. 1 of almost any other nation.

In March she won a half marathon in China. The sample taken after that race came back positive. The Athletics Integrity Unit (AIU) issued its statement on Thursday. She had been provisionally suspended since 10 September, and the six-year ban is counted from the same date. The statement gives no time, no split, no field quality for that race — only that she won it.

Six years. At 32, that means a return at roughly 38. In the depth of Ethiopian women's marathoning, a 38-year-old with a doping record on her name does not appear on a selection sheet. The 2028 Olympic cycle is closed to her entirely.

Now the part the media got wrong, and which is the legal centre of the whole case. Reports called methylprednisolone a "prohibited steroid" and said WADA classes it as performance enhancing. That is imprecise. Methylprednisolone is a glucocorticoid — WADA Prohibited List class S9, not an anabolic steroid (S1). And under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes.

Which means something simple. A therapeutic knee injection, given out of competition, is entirely legal. It becomes a violation only if residues are present in-competition. A road race's testing window opens at 23:59 the day before the race — so an injection given days earlier gets caught. A defence existed: route, timing, medical necessity. All three were arguable. And that is precisely the defence she closed herself.

The photo finish lied to me once — Imphal, 2026 — and I learned to read the crowd before the clock. The clock is a claim, not a verdict. In this case the claim was that a knee was being treated. A prescription was manufactured to support the claim. The prescription stopped being a tool and became evidence.

Look at the arithmetic. Two years for the presence violation. Four years for tampering. Six in total. The sum is itself a finding. Two years means the panel accepted the presence violation but did not treat intent as aggravating — the standard bracket for a Specified Substance, where a no-significant-fault argument is available. Four years means the panel treated the document fraud as wholly culpable. The near-paradox: a forged prescription is itself circumstantial evidence of concealment intent, yet it did not escalate the presence sanction. The panel weighed the two on separate scales.

The knee injury. That is the root cause, and it is a systemic signal, not an individual one. Chronic knee pathology is not an exception among marathoners. At 32, with appearance-fee income on the line, the pressure to mask pain is real. A glucocorticoid injection is the cheapest, most available tool against that pressure. It is standard sports medicine, not a secret.

But standard practice requires a credentialed team physician and a TUE framework. Neither appears here. The prescription was written by a family member, in the name of a clinic that did not exist. When an athlete has legitimate paperwork, she does not manufacture fake paperwork. The forgery here is not a disease; it is a literacy gap — the system's, and hers too.

One line on that March race in China. The Chinese label-race circuit is large appearance fees, a deep East African elite field, and now the AIU's highest-yield testing ground. The fee economy and the testing economy are colliding in the same race. Her result and prize money from it are almost certainly void, though the statement does not say so.

Here is an uncomfortable question, and I will not dodge it. Six years for a substance with no proven endurance benefit. Glucocorticoids do not make a marathon faster. The bulk of this sanction was not earned by the substance — it was earned by the paper.

Two readings are possible. First: AIU rigour, and it is correct that documentary fraud should not be treated leniently, or every case becomes a story about a pad. Second: uneven enforcement against East African road runners, where two years and six years in comparable matters can turn on which lawyer and which manager an athlete had sitting beside her.

I lean toward the second reading, with a condition: the inequality is not in the severity of the sanction, it is in the quality of the defence. Aga did not get six years because she is African. She got six years because nobody around her said: don't make the prescription, explain the timing.

And one thing nobody is writing: the 2026 Tokyo title does not automatically fall. The violation is anchored to a later March race; earlier results go only if earlier use is found. Commercially, though, she is now radioactive — in a sport where distance-running sponsorship is already thin.

The enforcement frontier has moved. The old question was what turned up in the sample. The new question is who signed the paper, and whether anyone checked the clinic's registration. Watch the next few months for whether the AIU reaches the managers and agents who commission such prescriptions, or whether the sanction stops at the athlete. A host does not own the microphone; she borrows the crowd. In this case the mic was in Aga's hand, but someone else wrote the script.